Regencell Bioscience Lim... (RGC)
25.66
-9.21 (-26.41%)
At close: Mar 28, 2025, 3:59 PM
25.05
-2.38%
After-hours: Mar 28, 2025, 06:48 PM EDT
Regencell Bioscience Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY13 | FY12 | FY11 | FY10 | FY09 | FY07 | FY06 | FY05 | FY04 | FY02 |
| Net Income | -4.36M | -6.06M | -7.59M | -1.35M | -812.37K | -390.99K | 112.3M | 170.4M | 153.4M | 105.6M | 157.7M | 144.8M | 77.6M | 95.5M | 72M | 363M | 86M | 82M | 185M | 117M |
| Depreciation & Amortization | 745.59K | 769.69K | 604.4K | 26.46K | 9.52K | n/a | 254.8M | 230.7M | 216.8M | 212M | 204.5M | 186.2M | 226.2M | 201.9M | 202M | 183M | 197M | 174M | 158M | 134M |
| Stock-Based Compensation | 449.31K | 922.62K | 2.76M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Working Capital | -585.37K | -508.94K | -1.02M | 552.98K | 76.28K | n/a | -37.8M | -23.6M | -3.9M | -40M | 8.6M | -42.2M | 8.5M | 11.6M | -93M | -2M | -315M | 73.1M | -36M | 85M |
| Other Non-Cash Items | -248K | -85.4K | -10.73K | 52.91K | 19.03K | n/a | 68M | 65.6M | 31.3M | 71.6M | -34.9M | 128.5M | -9.3M | 64.5M | 101.1M | -18.8M | 61.6M | 73.9M | n/a | 23M |
| Deferred Income Tax | n/a | 1.42K | n/a | n/a | n/a | n/a | 600K | 2.4M | -10.9M | -6.6M | 11.8M | -52.4M | 7.5M | -1.1M | -18M | -4M | -19M | 2M | 26M | 73M |
| Change in Working Capital | -585.37K | -508.94K | -1.02M | 552.98K | 76.28K | n/a | -35M | -67.4M | 35.5M | -42.9M | -1.5M | -70.8M | -51M | 44.1M | -92.1M | 271.8M | -29.6M | 50.1M | 102M | 24M |
| Operating Cash Flow | -4M | -4.96M | -5.27M | -767.31K | -726.57K | -390.99K | 409.9M | 410.5M | 434.4M | 349.1M | 346.9M | 346.6M | 259.4M | 410.8M | 270M | 800M | 304M | 387M | 476M | 373M |
| Capital Expenditures | -5.38K | -27.39K | -780.88K | n/a | -117.84K | n/a | -250.4M | -214.9M | -185.7M | -156.8M | -112.1M | -89.2M | -98.4M | -108.8M | n/a | n/a | n/a | n/a | n/a | n/a |
| Acquisitions | n/a | 970.00 | n/a | n/a | n/a | n/a | -171.6M | n/a | n/a | n/a | -194.4M | -89.7M | -55M | n/a | -209M | n/a | -34M | -223M | n/a | n/a |
| Purchase of Investments | -5M | -10M | -10M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 10.25M | 10.09M | n/a | n/a | n/a | n/a | n/a | 3.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 86.37 | -10K | n/a | n/a | n/a | 11.4M | -12.3M | 2.4M | 287.2M | 157.3M | 248.5M | 70.7M | -1.7M | -129M | -47M | -117M | -83M | -181M | -115M |
| Investing Cash Flow | 5.24M | 58.98K | -10.78M | n/a | -117.84K | n/a | -410.6M | -223.6M | -183.3M | 130.4M | -149.2M | 69.6M | -82.7M | -110.5M | -338M | -47M | -151M | -306M | -181M | -115M |
| Debt Repayment | n/a | n/a | n/a | 612.06K | 988.08K | 480.99K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | -228.8M | n/a | n/a | -147.1M | -280.9M | -109.5M | -205.3M | -400K | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 102.28K | 134.91K | -267.97K | -172.31K | n/a | n/a | -17M | -160M | -178.6M | -332.4M | 83.2M | -306.7M | -299.5M | -142.4M | n/a | -480M | -186M | n/a | -281M | -50M |
| Financial Cash Flow | 102.28K | 134.91K | 22.41M | 439.75K | 988.08K | 480.99K | -17M | -160M | -178.6M | -332.4M | 83.2M | -306.7M | -299.5M | -142.4M | n/a | -480M | -186M | n/a | -281M | -50M |
| Net Cash Flow | 1.4M | -4.85M | 6.36M | -327.57K | 143.67K | 90K | -17.7M | 26.9M | 72.5M | -132.9M | 171.9M | -143.5M | -122.8M | 157.9M | -68M | 273M | -34M | 81M | 12M | 208M |
| Free Cash Flow | -4.01M | -4.99M | -6.05M | -767.31K | -844.41K | -390.99K | 159.5M | 195.6M | 248.7M | 192.3M | 234.8M | 257.4M | 161M | 302M | 270M | 800M | 304M | 387M | 476M | 373M |